Skip to content
healthcare.dev

Glyburide

NDC 71209-011, Glyburide, tablet, from Cadila Pharmaceuticals Limited.

Product NDC
71209-011
Status
Listed
Labeler
Cadila Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203379
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71209-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYBURIDE5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
71209-011-0571209001105100 TABLET in 1 BOTTLE (71209-011-05)
71209-011-1071209001110500 TABLET in 1 BOTTLE (71209-011-10)
71209-011-11712090011111000 TABLET in 1 BOTTLE (71209-011-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea7a055b-64f0-46bf-aa8e-4a2ef5c3c035

Use it

Look up 71209-011 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71209-011 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71209-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.